Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of treatment interruption and intensification of antiretroviral therapy on health-related quality of life in patients with advanced HIV: a randomized, controlled trial.
Joyce VR, Barnett PG, Chow A, Bayoumi AM, Griffin SC, Sun H, Holodniy M, Brown ST, Kyriakides TC, Cameron DW, Youle M, Sculpher M, Anis AH, Owens DK. Joyce VR, et al. Among authors: kyriakides tc. Med Decis Making. 2012 Jan-Feb;32(1):70-82. doi: 10.1177/0272989X10397615. Epub 2011 Mar 7. Med Decis Making. 2012. PMID: 21383086 Clinical Trial.
An open-label randomized clinical trial of novel therapeutic strategies for HIV-infected patients in whom antiretroviral therapy has failed: rationale and design of the OPTIMA Trial.
Kyriakides TC, Babiker A, Singer J, Cameron W, Schechter MT, Holodniy M, Brown ST, Youle M, Gazzard B; OPTIMA Study Team. Kyriakides TC, et al. Control Clin Trials. 2003 Aug;24(4):481-500. doi: 10.1016/s0197-2456(03)00029-1. Control Clin Trials. 2003. PMID: 12865041 Clinical Trial.
Health-related quality of life in a randomized trial of antiretroviral therapy for advanced HIV disease.
Joyce VR, Barnett PG, Bayoumi AM, Griffin SC, Kyriakides TC, Yu W, Sundaram V, Holodniy M, Brown ST, Cameron W, Youle M, Sculpher M, Anis AH, Owens DK. Joyce VR, et al. Among authors: kyriakides tc. J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):27-36. doi: 10.1097/QAI.0b013e31818ce6f3. J Acquir Immune Defic Syndr. 2009. PMID: 19295332 Clinical Trial.
Quality of life of patients with advanced HIV/AIDS: measuring the impact of both AIDS-defining events and non-AIDS serious adverse events.
Anis AH, Nosyk B, Sun H, Guh DP, Bansback N, Li X, Barnett PG, Joyce V, Swanson KM, Kyriakides TC, Holodniy M, Cameron DW, Brown ST; OPTIMA Team1. Anis AH, et al. Among authors: kyriakides tc. J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):631-9. doi: 10.1097/QAI.0b013e3181a4f00d. J Acquir Immune Defic Syndr. 2009. PMID: 19430303 Clinical Trial.
Results of antiretroviral treatment interruption and intensification in advanced multi-drug resistant HIV infection from the OPTIMA trial.
Holodniy M, Brown ST, Cameron DW, Kyriakides TC, Angus B, Babiker A, Singer J, Owens DK, Anis A, Goodall R, Hudson F, Piaseczny M, Russo J, Schechter M, Deyton L, Darbyshire J; OPTIMA Team. Holodniy M, et al. Among authors: kyriakides tc. PLoS One. 2011 Mar 31;6(3):e14764. doi: 10.1371/journal.pone.0014764. PLoS One. 2011. PMID: 21483491 Free PMC article. Clinical Trial.
Cost-effectiveness of newer antiretroviral drugs in treatment-experienced patients with multidrug-resistant HIV disease.
Bayoumi AM, Barnett PG, Joyce VR, Griffin SC, Sun H, Bansback NJ, Holodniy M, Sanders G, Brown ST, Kyriakides TC, Angus B, Cameron DW, Anis AH, Sculpher M, Owens DK. Bayoumi AM, et al. Among authors: kyriakides tc. J Acquir Immune Defic Syndr. 2013 Dec 1;64(4):382-91. doi: 10.1097/QAI.0000000000000002. J Acquir Immune Defic Syndr. 2013. PMID: 24129369 Free PMC article.
GBV-C viremia and clinical events in advanced HIV infection.
Sahni H, Kirkwood K, Kyriakides TC, Stapleton J, Brown ST, Holodniy M; OPTIMA Study Team. Sahni H, et al. Among authors: kyriakides tc. J Med Virol. 2014 Mar;86(3):426-32. doi: 10.1002/jmv.23845. Epub 2013 Nov 19. J Med Virol. 2014. PMID: 24249700 Clinical Trial.
93 results